HoneyBear Biosciences, IncFounded in 2021, HoneyBear Biosciences, Inc is a Taiwan-based biotech company with a vision for global pharmaceutical market. We strive to develop new antibody technologies to bring novel therapeutics to the cancer patients. Our business strategy is to utilize our powerful platform to develop and commercialize novel Antibody-Drug Conjugates (ADC) through licensing and co-development partnership with biotech or pharmaceutical companies.